205 results on '"Moore, Assaf"'
Search Results
2. SABR-Dual: a phase II/III trial of two-fraction versus five-fraction stereotactic radiotherapy for localized low- and favorable intermediate-risk prostate cancer
3. Long-term Outcomes from a Phase 1 Dose Escalation Study Using Stereotactic Body Radiotherapy for Patients with Low- or Intermediate-risk Prostate Cancer
4. Local Failure after Prostate SBRT Predominantly Occurs in the PI-RADS 4 or 5 Dominant Intraprostatic Lesion
5. Postoperative positron emission tomography–computed tomography (PET-CT) in patients (Pts) with pathological stage III colon cancer (CC): Results from the first prospective validation study.
6. 40 Gray in 5 Fractions for Salvage Reirradiation of Spine Lesions Previously Treated With Stereotactic Body Radiotherapy.
7. Effect of Radiological Tumor Thickness on Prognosis of Early Glottic-Squamous Cell Carcinoma Treated With Radiation
8. Early outcomes of high-dose-rate brachytherapy combined with ultra-hypofractionated radiation in higher-risk prostate cancer
9. Bevacizumab for stereotactic radiosurgery-induced radiation necrosis in patients with non-small cell lung cancer treated with immune check-point inhibitors
10. The role of a radiopaque peri-rectal hydrogel spacer in aiding accurate daily image-guidance for prostate stereotactic radiotherapy.
11. Long-term Outcomes from a Phase 1 Dose Escalation Study Using Stereotactic Body Radiotherapy for Patients with Low- or Intermediate-risk Prostate Cancer
12. Stereotactic body radiation therapy (SBRT) for the treatment of primary lung cancer in recipients of lung transplant
13. The impact of endogenous estrogen exposures on the characteristics and outcomes of estrogen receptor positive, early breast cancer
14. Endobronchial brachytherapy—A novel approach for the management of airway amyloidosis
15. Outcome of radiotherapy for the treatment of laryngeal squamous cell carcinoma in the very elderly population.
16. SABR-Dual: A phase II/III trial of two-fraction versus five-fraction stereotactic radiotherapy for localized low- and favorable intermediate-risk prostate cancer
17. 731: Assessing metastasis-directed therapy in oligometastatic disease using restricted mean survival time
18. Same-day versus delayed simulation imaging after placement of a perirectal hydrogel spacer for prostate radiotherapy
19. Hypofractionated Radiation Therapy (Hypo-RT) for the Treatment of Localized Bladder Cancer
20. RET Fusion Lung Carcinoma: Response to Therapy and Clinical Features in a Case Series of 14 Patients
21. The effect of radiotherapy on taste sensation in head and neck cancer patients – a prospective study
22. Young-onset gastric cancer and Epstein–Barr Virus (EBV) – a major player in the pathogenesis?
23. Acute Toxicity and Early Prostate Specific Antigen Response After Two-Fraction Stereotactic Radiation Therapy for Localized Prostate Cancer Using Peri-Rectal Spacing – Initial Report of the SABR-Dual Trial
24. The effect of gastric fundus radiation dose on postoperative anastomotic leakage in esophageal cancer
25. Outcome of radiotherapy for the treatment of laryngeal squamous cell carcinoma in the very elderly population
26. First-line programmed death-1 inhibitor treatment for locoregionally advanced or metastatic cutaneous squamous cell carcinoma – A real-world experience from Israel
27. GSOR25 Presentation Time: 12:30 PM
28. Health Disparities in Prostate Cancer and Approaches to Advance Equitable Care
29. 1965: Acute toxicity after SABR to the prostate and pelvic lymph nodes for high-risk prostate cancer
30. Not only for melanoma. Subcutaneous pseudoprogression in lung squamous-cell carcinoma treated with nivolumab: A case report
31. Favorable toxicity of chemoradiation for muscle-invasive bladder cancer in elderly, frail patients.
32. Prognostic impact of HER2-low expression in hormone receptor positive early breast cancer
33. The Cost of Enfortumab Vedotin Wastage Due to Vial Size—A Real-World Analysis
34. The Impact of Exogenous Estrogen Exposure on the Characteristics and Outcome of Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Early-Stage Breast Cancer
35. Locoregional therapy in de novo metastatic breast cancer: Systemic review and meta-analysis
36. Use of Continuous Positive Airway Pressure (CPAP) to Limit Diaphragm Motion—A Novel Approach for Definitive Radiation Therapy for Inoperable Pleural Mesothelioma: A Pilot Study
37. Next-generation sequencing in thyroid cancers: do targetable alterations lead to a therapeutic advantage?
38. The Impact of Endogenous Estrogen Exposures on the Characteristics and Outcomes of Estrogen Receptor Positive, Early-stage Breast Cancer
39. PP09 Presentation Time: 11:20 AM
40. BAP1-Altered Malignant Pleural Mesothelioma: Outcomes With Chemotherapy, Immune Check-Point Inhibitors and Poly(ADP-Ribose) Polymerase Inhibitors
41. Abstract PS14-13: National comprehensive cancer network (NCCN) recommendations for drugs without US food and drug administration (FDA) approval in metastatic breast cancer: A cross-sectional study
42. Abstract PS1-50: Locoregional therapy in de novo metastatic breast cancer: Systemic review and meta-analysis
43. Abstract PS8-21: The impact of exogenous estrogen exposure on the characteristics of estrogen receptor (ER) positive, early-stage breast cancer (EBC)
44. ERBB2 Pathway in Biliary Tract Carcinoma: Clinical Implications of a Targetable Pathway
45. National comprehensive cancer network recommendations for drugs without US food and drug administration approval in metastatic breast cancer: A cross-sectional study
46. Potential Association between Kaposi Sarcoma and Gout: An Exploratory Observational Study
47. Volumetric modulated arc therapy (VMAT) is superior to intensity modulated radiotherapy (IMRT) for liver sparing in SBRT for hepatocellular carcinoma
48. Supraglottic Carcinoma in Intravenous Opioid Drug Abusers: A Distinct Disease with Improved Survival
49. Efficacy of immune‐checkpoint inhibitors in metastatic gastric or gastroesophageal junction adenocarcinoma by patient subgroups: A systematic review and meta‐analysis
50. Induction chemotherapy for locally advanced laryngeal and hypopharyngeal cancer: Single institution experience
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.